Dopamine in Neonate

• Status: Enrolling by invitation
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the pharmacokinetics and pharmacodynamics of dopamine which is used as treatment of hypotension in neonate and preterm infant.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborators: Asan Medical Center; Severance Hospital
• Treatments: Dopamine

Criteria

Inclusion Criteria:

• Admitted at NICU in Seoul National University Hospital, Seoul Asan Hospital or Severance Hospital

• Infants who were diagnosed with hypotension

Exclusion Criteria:

• Congenital heart disease

• Chromosomal anomaly

• Treated with ECMO or CRRT

• Arrhythmia

• Hypovolemic state